Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinoff
MedTech
Medtronic to spin out diabetes division as $2.8B company
The medtech giant said it aims to complete the spinoff within the next 18 months, with the goal of taking the new company public through an IPO.
Conor Hale
May 21, 2025 10:40am
Teleflex buys Biotronic’s vascular catalog, plans company split
Feb 27, 2025 11:00am
BD bids farewell to its diagnostic, bioscience divisions
Feb 6, 2025 1:10pm
Advantage spins out anti-aging R&D to new biotech Klothea
Nov 25, 2024 11:56am
Grail to become an Illumina spinout, once again, and go public
Jun 3, 2024 5:45pm
BridgeBio taps VCs for $200M to fund cancer-focused spinout
May 2, 2024 7:00am
